Cell penetrating peptide mediated quantum dot delivery and release in live mammalian cells

2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2014

Volumn , Issue , 2014, Pages 4260-4263

  Xu, Jianquan ^a   Yu, Yiyi ^c   Lee, Hao Chih ^c   Fan, Qirui ^b   Winter, Jessica ^b   Yang, Ge ^c  

^a University of Georgia   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c Ohio State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CYTOLOGY; MAMMALS; MOLECULAR BIOLOGY; NANOCRYSTALS; PEPTIDES;

BIOLOGICAL IMAGING; CELL-PENETRATING PEPTIDE; DELIVERY MECHANISM; FLUORESCENCE PROPERTIES; HIGH REPRODUCIBILITY; INTRACELLULAR IMAGING; SEMICONDUCTOR NANOCRYSTALS; THERAPEUTIC APPLICATION;

SEMICONDUCTOR QUANTUM DOTS;

CELL PENETRATING PEPTIDE; QUANTUM DOT;

ANIMAL; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; ENDOCYTOSIS; FLUORESCENCE MICROSCOPY; HUMAN; METABOLISM; PC12 CELL LINE; RAT; REPRODUCIBILITY; STAINING;

ANIMALS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL-PENETRATING PEPTIDES; ENDOCYTOSIS; HUMANS; MICROSCOPY, FLUORESCENCE; PC12 CELLS; QUANTUM DOTS; RATS; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING;

EID: 84946197320     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/EMBC.2014.6944565     Document Type: Conference Paper

References (28)

1. F. Pinaud, X. Michalet, L. A. Bentolila et al., "Advances in fluorescence imaging with quantum dot bio-probes," Biomaterials, Vol. 27, no. 9, pp. 1679-1687, 2006.
2. J. B. Delehanty, H. Mattoussi, and I. L. Medintz, "Delivering quantum dots into cells: strategies, progress and remaining issues," Analytical and Bioanalytical Chemistry, Vol. 393, no. 4, pp. 1091-1105, 2009.
3. A. Astriab-Fisher, D. Sergueev, M. Fisher et al., "Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: Effects on cellular uptake, binding to target sequences, and biologic actions," Pharmaceutical Research, Vol. 19, no. 6, pp. 744-754, 2002.
4. A. Nori, K. D. Jensen, M. Tijerina et al., "Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells," Bioconjugate Chemistry, Vol. 14, no. 1, pp. 44-50, 2003.
5. V. P. Torchilin, T. S. Levchenko, R. Rammohan et al., "Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes," Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, no. 4, pp. 1972-1977, 2003.
6. M. Lewin, N. Carlesso, C. H. Tung et al., "Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells," Nature Biotechnology, Vol. 18, no. 4, pp. 410-414, 2000.
7. M. Zhao, M. F. Kircher, L. Josephson et al., "Differential Conjugation of Tat Peptide to Superparamagnetic Nanoparticles and Its Effect on Cellular Uptake," Bioconjugate Chemistry, Vol. 13, no. 4, pp. 840-844, 2002.
8. G. Ruan, A. Agrawal, A. I. Marcus et al., "Imaging and Tracking of Tat Peptide-Conjugated Quantum Dots in Living Cells: New Insights into Nanoparticle Uptake, Intracellular Transport, and Vesicle Shedding," Journal of the American Chemical Society, Vol. 129, no. 47, pp. 14759-14766, 2007.
9. Y. E. Koshman, S. B. Waters, L. A. Walker et al., "Delivery and visualization of proteins conjugated to quantum dots in cardiac myocytes," Journal of Molecular and Cellular Cardiology, Vol. 45, no. 6, pp. 853-856, 2008.
10. B. R. Liu, Y. W. Huang, J. G. Winiarz et al., "Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism," Biomaterials, Vol. 32, no. 13, pp. 3520-3537, 2011.
11. A. E. Smith, and A. Helenius, "How viruses enter animal cells," Science, Vol. 304, no. 5668, pp. 237-242, 2004.
12. X. Han, J. H. Bushweller, D. S. Cafiso et al., "Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin," Nature Structural Biology, Vol. 8, no. 8, pp. 715-720, 2001.
13. J. S. Wadia, R. V. Stan, and S. F. Dowdy, "Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis," Nature Medicine, Vol. 10, no. 3, pp. 310-315, 2004.
14. Y. J. Lee, G. Johnson, and J. P. Pellois, "Modeling of the Endosomolytic Activity of HA2-TAT Peptides with Red Blood Cells and Ghosts," Biochemistry, Vol. 49, no. 36, pp. 7854-7866, 2010.
15. F. Duchardt, M. Fotin-Mleczek, H. Schwarz et al., "A comprehensive model for the cellular uptake of cationic cell-penetrating peptides," Traffic, Vol. 8, no. 7, pp. 848-866, 2007.
16. G. Tunnemann, R. M. Martin, S. Haupt et al., "Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells," FASEB Journal, Vol. 20, no. 11, pp. 1775-1784, 2006.
17. F. Madani, S. Lindberg, U. Langel et al., "Mechanisms of cellular uptake of cell-penetrating peptides," Journal of Biophysics, Vol. 2011, pp. 414729, 2011.
18. Y. J. Lee, S. Datta, and J. P. Pellois, "Real-time fluorescence detection of protein transduction into live cells," Journal of the American Chemical Society, Vol. 130, no. 8, pp. 2398-2399, 2008.
19. S. Abes, D. Williams, P. Prevot et al., "Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates," Journal of Controlled Release, Vol. 110, no. 3, pp. 595-604, 2006.
20. A. Erazo-Oliveras, N. Muthukrishnan, R. Baker et al., "Improving the Endosomal Escape of Cell-Penetrating Peptides and Their Cargos: Strategies and Challenges," Pharmaceuticals, Vol. 5, pp. 1177-1209, 2012.
21. H. W. Duan, and S. M. Nie, "Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings," Journal of the American Chemical Society, Vol. 129, no. 11, pp. 3333-3338, 2007.
22. M. Forgac, "Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology," Nature Reviews Molecular Cell Biology, Vol. 8, no. 11, pp. 917-929, 2007.
23. M. Serresi, R. Bizzarri, F. Cardarelli et al., "Real-time measurement of endosomal acidification by a novel genetically encoded biosensor," Analytical and Bioanalytical Chemistry, Vol. 393, no. 4, pp. 1123-1133, 2009.
24. M. Zorko, and U. Langel, "Cell-penetrating peptides: mechanism and kinetics of cargo delivery," Advanced Drug Delivery Reviews, Vol. 57, no. 4, pp. 529-545, 2005.
25. T. Takeuchi, M. Kosuge, A. Tadokoro et al., "Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate," ACS Chemical Biology, Vol. 1, no. 5, pp. 299-303, 2006.
26. M. Zhao, and R. Weissleder, "Intracellular cargo delivery using tat peptide and derivatives," Medicinal Research Reviews, Vol. 24, no. 1, pp. 1-12, 2004.
27. E. K. Esbjorner, K. Oglecka, P. Lincoln et al., "Membrane binding of pH-sensitive influenza fusion peptides. Positioning, configuration, and induced leakage in a lipid vesicle model," Biochemistry, Vol. 46, no. 47, pp. 13490-13504, 2007.
28. Y. J. Lee, G. Johnson, G. C. Peltier et al., "A HA2-Fusion tag limits the endosomal release of its protein cargo despite causing endosomal lysis," Biochimica Et Biophysica Acta-General Subjects, Vol. 1810, no. 8, pp. 752-758, 2011.